Lyle T, Verpeut J
J Neurosci. 2025; 45(7).
PMID: 39753302
PMC: 11823351.
DOI: 10.1523/JNEUROSCI.2182-23.2024.
Randakova A, Nelic D, Jakubik J
Sci Rep. 2023; 13(1):17587.
PMID: 37845324
PMC: 10579308.
DOI: 10.1038/s41598-023-45004-7.
Zeghal M, Laroche G, Freitas J, Wang R, Giguere P
Nat Commun. 2023; 14(1):3684.
PMID: 37407564
PMC: 10322906.
DOI: 10.1038/s41467-023-39132-x.
Wijayaratna D, Ratnayake K, Ubeysinghe S, Kankanamge D, Tennakoon M, Karunarathne A
Sci Rep. 2023; 13(1):2771.
PMID: 36797332
PMC: 9935898.
DOI: 10.1038/s41598-023-29639-0.
Bekic M, Vasiljevic M, Stojanovic D, Kokol V, Mihajlovic D, Vucevic D
Int J Nanomedicine. 2022; 17:3191-3216.
PMID: 35909813
PMC: 9329576.
DOI: 10.2147/IJN.S362038.
Chronic Chemogenetic Activation of the Superior Colliculus in Glaucomatous Mice: Local and Retrograde Molecular Signature.
Claes M, Geeraerts E, Plaisance S, Mentens S, Van den Haute C, De Groef L
Cells. 2022; 11(11).
PMID: 35681479
PMC: 9179903.
DOI: 10.3390/cells11111784.
Inhibition of Human Prostate and Bladder Smooth Muscle Contraction, Vasoconstriction of Porcine Renal and Coronary Arteries, and Growth-Related Functions of Prostate Stromal Cells by Presumed Small Molecule Gα Inhibitor, YM-254890.
Tamalunas A, Wendt A, Springer F, Ciotkowska A, Rutz B, Wang R
Front Physiol. 2022; 13:884057.
PMID: 35677088
PMC: 9168773.
DOI: 10.3389/fphys.2022.884057.
The DREADDful Hurdles and Opportunities of the Chronic Chemogenetic Toolbox.
Claes M, De Groef L, Moons L
Cells. 2022; 11(7).
PMID: 35406674
PMC: 8998042.
DOI: 10.3390/cells11071110.
Connecting nutritional deprivation and pubertal inhibition via GRK2-mediated repression of kisspeptin actions in GnRH neurons.
Perdices-Lopez C, Avendano M, Barroso A, Gaytan F, Ruiz-Pino F, Vazquez M
Metabolism. 2022; 129:155141.
PMID: 35074314
PMC: 10283027.
DOI: 10.1016/j.metabol.2022.155141.
Biased activation of β-AR/Gi/GRK2 signal pathway attenuated β-AR sustained activation induced by β-adrenergic receptor autoantibody.
Chen H, Cao N, Wang L, Wu Y, Wei H, Li Y
Cell Death Discov. 2021; 7(1):340.
PMID: 34750352
PMC: 8576015.
DOI: 10.1038/s41420-021-00735-2.
Acute Corticotropin-Releasing Factor Receptor Type 2 Agonism Results in Sustained Symptom Improvement in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Pereira G, Gillies H, Chanda S, Corbett M, Vernon S, Milani T
Front Syst Neurosci. 2021; 15:698240.
PMID: 34539356
PMC: 8441022.
DOI: 10.3389/fnsys.2021.698240.
Potential Regulatory Roles of GRK2 in Endothelial Cell Activity and Pathological Angiogenesis.
Kuai J, Han C, Wei W
Front Immunol. 2021; 12:698424.
PMID: 34335610
PMC: 8320431.
DOI: 10.3389/fimmu.2021.698424.
The LPA Receptor: Regulation and Activation of Signaling Pathways.
Solis K, Romero-Avila M, Guzman-Silva A, Garcia-Sainz J
Int J Mol Sci. 2021; 22(13).
PMID: 34201414
PMC: 8269014.
DOI: 10.3390/ijms22136704.
A blocking peptide stabilizes lysophosphatidic acid receptor 1 and promotes lysophosphatidic acid-induced cellular responses.
Taleb S, Wei J, Mialki R, Dong S, Li Y, Zhao J
J Cell Biochem. 2021; 122(8):827-834.
PMID: 33847006
PMC: 8934197.
DOI: 10.1002/jcb.29919.
Historical Perspective of the G Protein-Coupled Receptor Kinase Family.
Benovic J
Cells. 2021; 10(3).
PMID: 33806476
PMC: 7999923.
DOI: 10.3390/cells10030555.
Involvement of Lipids in Alzheimer's Disease Pathology and Potential Therapies.
Chew H, Solomon V, Fonteh A
Front Physiol. 2020; 11:598.
PMID: 32581851
PMC: 7296164.
DOI: 10.3389/fphys.2020.00598.
Dawn of a New RAMPage.
Serafin D, Harris N, Nielsen N, Mackie D, Caron K
Trends Pharmacol Sci. 2020; 41(4):249-265.
PMID: 32115276
PMC: 7236817.
DOI: 10.1016/j.tips.2020.01.009.
Editorial: G Protein-Coupled Receptor Kinases (GRKs) and β-Arrestins: New Insights Into Disease Regulators.
Hattori Y, Michel M
Front Pharmacol. 2020; 10:1654.
PMID: 32047443
PMC: 6997549.
DOI: 10.3389/fphar.2019.01654.
G protein-coupled receptor kinase 2 (GRK2) as a multifunctional signaling hub.
Penela P, Ribas C, Sanchez-Madrid F, Mayor Jr F
Cell Mol Life Sci. 2019; 76(22):4423-4446.
PMID: 31432234
PMC: 6841920.
DOI: 10.1007/s00018-019-03274-3.
New Routes in GPCR/β-Arrestin-Driven Signaling in Cancer Progression and Metastasis.
Bagnato A, Rosano L
Front Pharmacol. 2019; 10:114.
PMID: 30837880
PMC: 6390811.
DOI: 10.3389/fphar.2019.00114.